Kyprolis
Recall
|
Medicines
|
19/12/2016
The marketing authorization holder informed its supplied customers in a letter dated December 15, 2016, that the vials may have cracks in the glass. Therefore, the affected batch is being recalled as a precautionary measure. The company is not aware of any product complaints or adverse reaction reports in connection with this defect.
Name of the medicinal product | Kyprolis 30 mg Pulver zur Herstellung einer Infusionslösung |
---|---|
Marketing authorisation number(s) | EU/1/15/1060/003 |
Marketing authorisation holder | AmgenEurope B.V. Durchführung Rückruf: Amgen GmbH |
Batch number(s) | 1074018A |
Classification of the recall | § |
BASG reference number | INS - 640.001 - 1943 |
Further inquiry note
Page last modified:
12/07/2022